1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Tachyarrhythmia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leong, LL; Papadimitriou, JM; Stephens, CJ; Sturm, MJ; Taylor, RR | 1 |
| Holgate, ST; Jenkins, JR; Lai, CK; Polosa, R | 1 |
| Bigaud, M; Parratt, JR; Wainwright, CL | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Tachyarrhythmia
| Article | Year |
|---|---|
The effects of a PAF antagonist on ischemic myocardial damage and arrhythmia in the dog.
Topics: Animals; Arrhythmias, Cardiac; Azepines; Coronary Disease; Dogs; Myocardial Reperfusion Injury; Platelet Activating Factor; Tachycardia; Triazoles; Ventricular Fibrillation | 1992 |
Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects.
Topics: Administration, Inhalation; Adult; Bronchi; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Humans; Male; Maximal Expiratory Flow Rate; Methacholine Chloride; Methacholine Compounds; Middle Aged; Platelet Activating Factor; Tachycardia; Vital Capacity | 1990 |
The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion.
Topics: Acute Disease; Animals; Blood Gas Analysis; Cardiac Complexes, Premature; Coronary Disease; Disease Models, Animal; Diterpenes; Dogs; Drug Evaluation, Preclinical; Electrocardiography; Ginkgolides; Hemodynamics; Hydrogen-Ion Concentration; Lactones; Myocardial Reperfusion; Oxygen; Platelet Activating Factor; Platelet Count; Quinolinium Compounds; Random Allocation; Tachycardia; Time Factors; Ventricular Fibrillation | 1989 |